These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16096721)

  • 1. The role of exoproteases in governing intraneuronal metabolism of botulinum toxin.
    Simpson LL; Maksymowych AB; Kouguchi H; Dubois G; Bora RS; Joshi S
    Protein J; 2005 Apr; 24(3):155-65. PubMed ID: 16096721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a vertebrate neuromuscular junction that demonstrates selective resistance to botulinum toxin.
    Coffield JA; Bakry NM; Maksymowych AB; Simpson LL
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1509-16. PubMed ID: 10336546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroscience. A neuronal receptor for botulinum toxin.
    Jahn R
    Science; 2006 Apr; 312(5773):540-1. PubMed ID: 16645086
    [No Abstract]   [Full Text] [Related]  

  • 4. Site-directed mutagenesis identifies active-site residues of the light chain of botulinum neurotoxin type A.
    Rigoni M; Caccin P; Johnson EA; Montecucco C; Rossetto O
    Biochem Biophys Res Commun; 2001 Nov; 288(5):1231-7. PubMed ID: 11700044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
    Höltje M; Schulze S; Strotmeier J; Mahrhold S; Richter K; Binz T; Bigalke H; Ahnert-Hilger G; Rummel A
    Toxicon; 2013 Dec; 75():108-21. PubMed ID: 23817019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions.
    Ayyar BV; Aoki KR; Atassi MZ
    Infect Immun; 2015 Apr; 83(4):1465-76. PubMed ID: 25624352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum neurotoxins: new questions arising from structural biology.
    Kammerer RA; Benoit RM
    Trends Biochem Sci; 2014 Nov; 39(11):517-26. PubMed ID: 25282537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Structure and function of botulinum toxin].
    Fujii N
    Hokkaido Igaku Zasshi; 1995 Jan; 70(1):19-28. PubMed ID: 7744367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of botulinum toxin-induced changes in neuromuscular function with antibodies directed against recombinant polypeptides or fragments.
    Joshi SG; Elias M; Singh A; Al-Saleem FH; Ancharski D; Nasser Z; Takahashi T; Simpson LL
    Neuroscience; 2011 Apr; 179():208-22. PubMed ID: 21277940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of botulinum neurotoxin into cultured neurons.
    Keller JE; Cai F; Neale EA
    Biochemistry; 2004 Jan; 43(2):526-32. PubMed ID: 14717608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A modular and non pathogenic type A botulinum toxin].
    Darios F
    Med Sci (Paris); 2011; 27(8-9):694-6. PubMed ID: 21880251
    [No Abstract]   [Full Text] [Related]  

  • 12. Longer-acting and highly potent chimaeric inhibitors of excessive exocytosis created with domains from botulinum neurotoxin A and B.
    Wang J; Zurawski TH; Bodeker MO; Meng J; Boddul S; Aoki KR; Dolly JO
    Biochem J; 2012 May; 444(1):59-67. PubMed ID: 22360156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extravesicular intraneuronal migration of internalized botulinum neurotoxins without detectable inhibition of distal neurotransmission.
    Lawrence GW; Ovsepian SV; Wang J; Aoki KR; Dolly JO
    Biochem J; 2012 Jan; 441(1):443-52. PubMed ID: 21929507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Mechanism of the Beneficial Effect of Botulinum Toxin Type a Used in the Treatment of Temporomandibular Joints Dysfunction.
    Malgorzata P; Piotr C; Edward K
    Mini Rev Med Chem; 2017; 17(5):445-450. PubMed ID: 27151142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin.
    Bakry N; Kamata Y; Simpson LL
    J Pharmacol Exp Ther; 1991 Sep; 258(3):830-6. PubMed ID: 1653841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of botulinum neurotoxin serotype A.
    Wenzel RG
    Am J Health Syst Pharm; 2004 Nov; 61(22 Suppl 6):S5-10. PubMed ID: 15598004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The action of batulinum toxin at the neuromuscular junction.
    Sellin LC
    Med Biol; 1981 Feb; 59(1):11-20. PubMed ID: 6115105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering botulinum neurotoxin domains for activation by toxin light chain.
    Stancombe PR; Masuyer G; Birch-Machin I; Beard M; Foster KA; Chaddock JA; Acharya KR
    FEBS J; 2012 Feb; 279(3):515-23. PubMed ID: 22141396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage of intracellular substrates of botulinum toxins A, C, and D in a mammalian target tissue.
    Kalandakanond S; Coffield JA
    J Pharmacol Exp Ther; 2001 Mar; 296(3):749-55. PubMed ID: 11181902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mastoparan-7 rescues botulinum toxin-A poisoned neurons in a mouse spinal cord cell culture model.
    Zhang P; Ray R; Singh BR; Ray P
    Toxicon; 2013 Dec; 76():37-43. PubMed ID: 24047963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.